Cargando…
Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia
Methylmalonic acidemia (MMA) is a severe metabolic disorder most commonly caused by a mutation in the methylmalonyl-CoA mutase (MMUT) gene. Patients with MMA experience multisystemic disease manifestations and remain at risk for neurological disease progression, even after liver transplantation. The...
Autores principales: | May, Francis J., Head, PamelaSara E., Venturoni, Leah E., Chandler, Randy J., Venditti, Charles P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188058/ https://www.ncbi.nlm.nih.gov/pubmed/34169115 http://dx.doi.org/10.1016/j.omtm.2021.04.005 |
Ejemplares similares
-
In vivo genome editing at the albumin locus to treat methylmalonic acidemia
por: Schneller, Jessica L., et al.
Publicado: (2021) -
Long-term Rescue of a Lethal Murine Model of Methylmalonic Acidemia Using Adeno associated Viral Gene Therapy
por: Chandler, Randy J, et al.
Publicado: (2009) -
Systemic gene therapy for methylmalonic acidemia using the novel adeno-associated viral vector 44.9
por: Chandler, Randy J., et al.
Publicado: (2022) -
Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia
por: Chandler, Randy J., et al.
Publicado: (2021) -
Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle
por: Chandler, Randy J, et al.
Publicado: (2007)